CoChat

Effects of liver disease on urinary excretion of methadone and metabolites in maintenance patients: Quantitation by direct probe chemical ionization mass spectrometry

Kreek, Mary Jeanne, Bencsath, F. Aladar, Field, Frank H. · 1980 · Biological Mass Spectrometry

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Abstract

This study was performed to define the amounts of methadone and metabolites excreted in urine in otherwise healthy maintenance patients, and to determine whether the metabolism and elimination of methadone, as assessed by analyses of urines, is altered in patients with liver disease. A method was developed for the simultaneous quantitation of methadone and six of its major and minor metabolites using chemical ionization mass spectrometry with direct probe introduction to increase sensitivity for analyses of the minor metabolites. Analyses of urine from unmedicated volunteers showed that the interferences at the mass range of interest (264-326) were usually small and therefore would not introduce significant error into analysis. Nineteen patients well-stabilized in chronic long-term methadone treatment were studied, five otherwise healthy males and fourteen patients with chronic liver disease (nine males and four females). Twenty-four hour urine collections were made and analyzed following extraction procedures. The concentrations of methadone and the major pyrrolidine metabolite exceeded 1 microgram ml-1 in all cases; the concentration (listed in descending order) of pyrrolidone, pyrroline, hydroxymethadone, hydroxypyrroline, methadol and hydroxypyrrolidine were all less than 1 microgram ml-1. The total 24 hour urinary excretion of methadone and its metabolites was 48.3% (+/- 1.71 SEM) in otherwise healthy patients but was significantly lower, 32.6% (+/- 3.19 SEM) in patients with liver disease (p less than 0.05). The total 24 hour excretion of the pyrrolidone metabolite, the end product of two pathways of methadone metabolism, was also significantly reduced in patients with liver disease (p less than 0.05). Females with liver disease had significantly higher ratios of pyrrolidine to methadone than did males with liver disease (p less than 0.05).

Overview

Integrity signals

Registry

Crossref · 10.1002/bms.1200070906

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 35 references

Research works printed but not linked: 7

  1. Bond, 1978, Am. J. Hosp. Pharm., 35, 406
  2. Closson, 1977, Am. J. Hosp. Pharm., 34, 520
  3. Kreek, 1973, N. Y. State J. Med., 23, 2773
  4. Weinkam, 1976, Anal. Biochem., 48, 203
  5. Tong, 1979, Clin. Pharmacol. Ther., 25, 242
  6. Harte, 1976, Clin. Res., 24, 623a
  7. Bowen, 1978, Adv. Mass Spectrom., 7B, 1634

Cited by

See all 37

Metadata

Authors
Kreek, M. J., Bencsath, F. A., & Field, F. H.
Affiliations
Rockefeller University (US)
Venue
Biological Mass Spectrometry
Publisher
Wiley
Published
1980-09
Volume
7
Issue
9
Pages
385-395
ISSN
  • 1076-5174 (ISSN-L)
  • 1052-9306
  • 1096-9888
OpenAlex
W2138745161
Cited by
33
References
35
Citations by year
2018: 1 · 2013: 1 · 2012: 2
FWCI
0.38
Type
journal article
Language
en
Open access
closed
Licence
doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 12783 d)
Locations
  • Journal of Mass Spectrometry (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute on Drug Abuse
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
Keywords
methadone, methadone metabolites, chronic liver disease, urinary excretion, methadone maintenance treatment, pyrrolidinone, drug metabolism, elimination, sex differences, chemical ionization mass spectrometry
MeSH terms
Chronic Disease, Female, Heroin Dependence, Humans, Liver Diseases, Male, Methadone, Pyrrolidines, Sex Factors, Mass Spectrometry

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of liver disease on urinary excretion of methadone and metabolites in maintenance patients: Quantitation by direct probe chemical ionization mass spectrometry. https://app.cochat.ai/papers/10.1002/bms.1200070906
The paper
Kreek, M. J., Bencsath, F. A., & Field, F. H. (1980). Effects of liver disease on urinary excretion of methadone and metabolites in maintenance patients: Quantitation by direct probe chemical ionization mass spectrometry. Biological Mass Spectrometry. https://doi.org/10.1002/bms.1200070906

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.